News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
314,887 Results
Type
Article (15959)
Company Profile (293)
Press Release (298625)
Multimedia
Podcasts (72)
Webinars (11)
Section
Business (94258)
Career Advice (199)
Deals (15919)
Drug Delivery (52)
Drug Development (52430)
Employer Resources (39)
FDA (6540)
Job Trends (6733)
News (164670)
Policy (11190)
Tag
Academia (1003)
Accelerated approval (9)
Adcomms (16)
Allergies (79)
Alliances (24081)
ALS (99)
Alzheimer's disease (990)
Antibody-drug conjugate (ADC) (166)
Approvals (6621)
Artificial intelligence (218)
Autoimmune disease (51)
Automation (14)
Bankruptcy (114)
Best Places to Work (5395)
BIOSECURE Act (8)
Biosimilars (86)
Biotechnology (233)
Bladder cancer (84)
Brain cancer (35)
Breast cancer (270)
Cancer (2545)
Cardiovascular disease (207)
Career advice (175)
Career pathing (4)
CAR-T (192)
CDC (8)
Cell therapy (501)
Cervical cancer (14)
Clinical research (43937)
Collaboration (914)
Company closure (2)
Compensation (473)
Complete response letters (36)
COVID-19 (1158)
CRISPR (73)
C-suite (394)
Cystic fibrosis (101)
Data (3048)
Denatured (13)
Depression (71)
Diabetes (232)
Diagnostics (2078)
Digital health (13)
Diversity (4)
Diversity, equity & inclusion (11)
Drug discovery (139)
Drug pricing (50)
Drug shortages (5)
Duchenne muscular dystrophy (179)
Earnings (37787)
Editorial (21)
Employer branding (4)
Employer resources (36)
Events (53013)
Executive appointments (674)
FDA (8019)
Fibrodysplasia Ossificans Progressiva (3)
Friedreich's ataxia (5)
Frontotemporal dementia (13)
Funding (861)
Gene editing (145)
Generative AI (17)
Gene therapy (414)
GLP-1 (505)
Government (1278)
Grass and pollen (3)
Guidances (211)
Healthcare (7969)
HIV (15)
Huntington's disease (34)
IgA nephropathy (49)
Immunology and inflammation (167)
Immuno-oncology (9)
Indications (38)
Infectious disease (1261)
Inflammatory bowel disease (142)
Inflation Reduction Act (9)
Influenza (37)
Intellectual property (133)
Interviews (22)
IPO (8461)
IRA (16)
Job creations (1622)
Job search strategy (161)
Kidney cancer (10)
Labor market (17)
Layoffs (254)
Leadership (8)
Legal (1563)
Liver cancer (41)
Longevity (9)
Lung cancer (376)
Lymphoma (190)
Machine learning (17)
Management (9)
Manufacturing (370)
MASH (108)
Medical device (4028)
Medtech (4037)
Mergers & acquisitions (8050)
Metabolic disorders (634)
Multiple sclerosis (89)
NASH (17)
Neurodegenerative disease (148)
Neuropsychiatric disorders (47)
Neuroscience (1717)
NextGen: Class of 2025 (2454)
Non-profit (1065)
Now hiring (28)
Obesity (286)
Opinion (123)
Ovarian cancer (109)
Pain (80)
Pancreatic cancer (112)
Parkinson's disease (184)
Partnered (10)
Patents (245)
Patient recruitment (218)
Peanut (40)
People (30013)
Pharmaceutical (49)
Pharmacy benefit managers (6)
Phase I (15711)
Phase II (20373)
Phase III (12853)
Pipeline (1892)
Policy (91)
Postmarket research (894)
Preclinical (6496)
Press Release (36)
Prostate cancer (122)
Psychedelics (46)
Radiopharmaceuticals (230)
Rare diseases (476)
Real estate (3196)
Recruiting (16)
Regulatory (10281)
Reports (23)
Research institute (1032)
Resumes & cover letters (25)
Rett syndrome (13)
RNA editing (15)
RSV (25)
Schizophrenia (106)
Series A (151)
Series B (115)
Service/supplier (1)
Sickle cell disease (57)
Special edition (16)
Spinal muscular atrophy (119)
Sponsored (17)
Startups (2157)
State (1)
Stomach cancer (6)
Supply chain (42)
Tariffs (32)
The Weekly (58)
Vaccines (350)
Venture capital (45)
Weight loss (169)
Women's health (24)
Worklife (2)
Date
Today (73)
Last 7 days (331)
Last 30 days (1485)
Last 365 days (20125)
2025 (15614)
2024 (22580)
2023 (24688)
2022 (31084)
2021 (32253)
2020 (26971)
2019 (19347)
2018 (14110)
2017 (15598)
2016 (13356)
2015 (16156)
2014 (11644)
2013 (8429)
2012 (8699)
2011 (8850)
2010 (8441)
Location
Africa (190)
Alabama (61)
Alaska (3)
Arizona (74)
Arkansas (7)
Asia (20217)
Australia (3406)
California (6109)
Canada (1703)
China (624)
Colorado (227)
Connecticut (226)
Delaware (175)
Europe (43319)
Florida (788)
Georgia (187)
Hawaii (2)
Idaho (23)
Illinois (396)
India (29)
Indiana (188)
Iowa (10)
Japan (182)
Kansas (75)
Kentucky (14)
Louisiana (9)
Maine (45)
Maryland (721)
Massachusetts (4755)
Michigan (135)
Minnesota (248)
Mississippi (4)
Missouri (39)
Montana (16)
Nebraska (6)
Nevada (38)
New Hampshire (41)
New Jersey (1518)
New Mexico (17)
New York (1596)
North Carolina (788)
North Dakota (6)
Northern California (2825)
Ohio (158)
Oklahoma (14)
Oregon (25)
Pennsylvania (1147)
Puerto Rico (9)
Rhode Island (28)
South America (309)
South Carolina (18)
South Dakota (1)
Southern California (2397)
Tennessee (72)
Texas (806)
United States (20896)
Utah (96)
Virginia (125)
Washington D.C. (37)
Washington State (506)
West Virginia (3)
Wisconsin (34)
Wyoming (1)
314,887 Results for "expansion therapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
MannKind Announces Expansion of United Therapeutics Collaboration for Second Inhaled Therapy
August 28, 2025
·
3 min read
Press Releases
Astria Therapeutics Initiates the Phase 3 ORBIT-EXPANSE Long-Term Trial of Navenibart in People with Hereditary Angioedema
October 9, 2025
·
6 min read
Press Releases
Hoth Therapeutics Announces Engagement with ICON and Expansion of Phase II Clinical Trial for HT-001 in Europe
July 30, 2025
·
4 min read
Press Releases
Aquestive Therapeutics Provides International Expansion Update for Anaphylm™ (epinephrine) Sublingual Film
July 16, 2025
·
9 min read
Press Releases
Tasca Therapeutics Doses First Patient in Phase 1/2 Dose Escalation and Expansion Trial Evaluating CP-383 in Advanced Solid Tumors
September 17, 2025
·
2 min read
Press Releases
Kraig Biocraft Laboratories Announces Production Expansion
October 6, 2025
·
3 min read
Press Releases
Palvella Therapeutics Announces Expansion of QTORIN™ Rapamycin’s Development into Clinically Significant Angiokeratomas, a Rare, Chronically Debilitating Lymphatic Disease with No FDA-approved Therapies
September 24, 2025
·
7 min read
Press Releases
Allarity Therapeutics Provides Second Quarter 2025 Update, Highlighting Clinical Progress, IP Expansion, and New Partnerships
August 18, 2025
·
13 min read
Press Releases
Augurex Announces Expansion of Availability of the JOINTstat® Diagnostic Test for Rheumatoid Arthritis with MitogenDx
October 16, 2025
·
3 min read
Press Releases
Marengo Therapeutics Advances STARt-002 Clinical Trial into Phase 2 Cohort Expansion Evaluating Invikafusp Alfa with TROP2-directed ADC TRODELVY® in Metastatic Breast Cancer
September 18, 2025
·
4 min read
1 of 31,489
Next
